Selective Immune Inhibitor Safely Restrains Autoimmune Responses (2 of 3) (IMAGE)

American Association for the Advancement of Science (AAAS)

Selective Immune Inhibitor Safely Restrains Autoimmune Responses (2 of 3)

Caption

Authors pictured (from left to right): Julie Carman, Yifan Zhang, Joann Strnad, Elizabeth Heimrich, Adriana Zupa-Fernandez, Anjaneya Chimalakonda, Jinwen Huang, Lihong Cheng, Dana Banas, James Burke, Charu Chaudhry, Jian Pang, Ryan Moslin, Stephen Wrobleski, Sha Li, Xiadi Zhou, Jenny Xie. This material relates to a paper that appeared in the Jul. 24, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by J.R. Burke at Bristol-Myers Squibb Research and Development in Princeton, NJ.; and colleagues was titled, "Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain."

Credit

Bristol-Myers Squibb Company

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.